戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y due to distant metastasis but not regional lymphatic metastasis.
2 rkedly promotes tumour lymphangiogenesis and lymphatic metastasis.
3 argely restores tumour lymphangiogenesis and lymphatic metastasis.
4 ugh the stimulation of lymphangiogenesis and lymphatic metastasis.
5 ates TNF-alpha-induced lymphangiogenesis and lymphatic metastasis.
6 ivity, was involved in lymphangiogenesis and lymphatic metastasis.
7  this was required for lymphangiogenesis and lymphatic metastasis.
8 ulation during inflammation, lymphedema, and lymphatic metastasis.
9 tion of the primary tumor, blood vessel, and lymphatic metastasis.
10  and, consequently, plays a critical role in lymphatic metastasis.
11 NO synthase (NOS) expression correlates with lymphatic metastasis.
12 phatic vascular surface areas, and increased lymphatic metastasis.
13 hese effects would reduce the probability of lymphatic metastasis.
14 vel approach for prevention and treatment of lymphatic metastasis.
15 ronment, local invasiveness, and facilitated lymphatic metastasis.
16 xpression was linked with clinical stage and lymphatic metastasis.
17  the lymphatic system, such as lymphedema or lymphatic metastasis.
18 genous metastasis, but is dispensable during lymphatic metastasis(2).
19 in the tumor margin alone are sufficient for lymphatic metastasis and should be targeted therapeutica
20 is and in the control of hematogenous versus lymphatic metastasis are unknown.
21 oanatomic niche preparation that facilitates lymphatic metastasis by cancer cells.
22 ish a role for RORgammat(+)ILC3 in promoting lymphatic metastasis by modulating the local chemokine m
23 lassical pathway suppresses tumor growth and lymphatic metastasis by reducing chemokine production, r
24 sis, and propose therapeutic intervention of lymphatic metastasis by targeting the TNF-alpha-TNFR1 pa
25 ed the incidence and burden of pulmonary and lymphatic metastasis by TLR4-positive tumors.
26  3) and m2 (n = 5) layer infiltration had no lymphatic metastasis compared with 13% for m3 (n = 39).
27                                              Lymphatic metastasis contributes to mortality from solid
28 However, causal relationship between NOS and lymphatic metastasis has not been documented.
29 le in tumor-associated lymphangiogenesis and lymphatic metastasis has remained unclear.
30 phatic eye may explain the increased risk of lymphatic metastasis in ciliary body melanoma with extra
31 l-mesenchymal transition (EMT), and lung and lymphatic metastasis in GC cells.
32                        Lymphangiogenesis and lymphatic metastasis in mice bearing human breast cancer
33 on lymphatic remodelling in vivo and reduces lymphatic metastasis in preclinical cancer models and in
34                                  The rate of lymphatic metastasis in submucosal carcinomas was 21% fo
35                                              Lymphatic metastasis is a critical determinant of cancer
36                                              Lymphatic metastasis is a high-impact prognostic factor
37    However, the mechanistic understanding of lymphatic metastasis is still in infancy.
38                   The molecular mechanism of lymphatic metastasis is, however, poorly understood.
39 and 3D cultures) and in vivo (mouse lung and lymphatic metastasis models) assays to evaluate the func
40   In this study, we show that HIF-1 promotes lymphatic metastasis of breast cancer by direct transact
41                                              Lymphatic metastasis of cancer cells involves movement f
42 c factors in promoting lymphangiogenesis and lymphatic metastasis remains poorly understood.
43 ings explain the correlation between NOS and lymphatic metastasis seen in a number of human tumors an
44                                In a model of lymphatic metastasis, Snord67 loss decreases LN tumor gr
45 mphatic surface area in the tumor margin and lymphatic metastasis, these tumors contained no function
46  Our results establish an anatomic basis for lymphatic metastasis to the breast from primary cutaneou
47  into HLECs to promote lymphangiogenesis and lymphatic metastasis via downregulation of VASH1 and may
48            An in vivo model of breast cancer lymphatic metastasis was established in mice.
49 opy that allows us to visualize the steps of lymphatic metastasis, we show that genetic deletion of e